This inventor holds 102 USPTO granted patents and 40 published patent applications, plus 16 CIPO patents and 44 EPO patents, primarily in Humanized Mice (CPC class A01K67-0278). Top assignees: Regeneron Pharmaceuticals, Inc., Institute for Research in Biomedicine, Yale University. Active years: 2014-2026.
Inventors with similar research interests:
Location History:
- Valhalla, NY (US) (2014 - 2020)
- Tarrytown, NY (US) (2020 - 2023)
- Chappaqua, NY (US) (2016 - 2024)
Company Filing History:
99 out of 1,473 
4 out of 76 
3 out of 1,362 
Years Active: 2014-2026
Areas of Expertise:
Title: The Innovative Journey of Cagan Gurer
Introduction:
Cagan Gurer, a prolific inventor based in Chappaqua, NY, has made significant contributions to the field of biotechnology with an impressive portfolio of 85 patents. His groundbreaking work has revolutionized the industry, particularly in the area of genetically modified non-human animals.
Latest Patents:
Among his latest patents, one that stands out is the "Humanized Light Chain Mice" patent. This invention involves the modification of endogenous non-human heavy chain immunoglobulin sequences to express human immunoglobulin heavy chain variable domains. These genetically engineered mice exhibit ADAM6 activity, showcasing Gurer's ingenuity in developing innovative research models for biopharmaceutical advancements.
Career Highlights:
With a notable career spanning across companies like Regeneron Pharmaceuticals, Inc. and Yale University, Cagan Gurer has established himself as a prominent figure in the biotech domain. His relentless pursuit of scientific excellence has led to numerous breakthroughs in the field, earning him recognition as a visionary inventor.
Collaborations:
Throughout his career, Gurer has collaborated with esteemed professionals such as Andrew J Murphy and Sean Stevens. These partnerships have not only fostered a culture of innovation but have also paved the way for multidisciplinary approaches in addressing complex challenges within the biotechnology sector.
Conclusion:
In conclusion, Cagan Gurer's unwavering dedication to pioneering novel solutions in biotechnology has reshaped the landscape of genetic research and development. His profound impact on the industry reverberates through his extensive patent portfolio, solidifying his legacy as a trailblazing inventor at the forefront of scientific innovation.